Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: Identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon

Frontiers in Microbiology

Volumn 6, Issue JAN, 2015, Pages

  Morita, Yuji ^a   Tomida, Junko ^a   Kawamura, Yoshiaki ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Efflux; MexEF oprN; MexS; MexXY oprA; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMPICILLIN; CARBENICILLIN; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VALINE;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GROWTH; BACTERIAL STRAIN; DNA ISOLATION; DNA SEQUENCE; ESCHERICHIA COLI; GENETIC COMPLEMENTATION; HOMOLOGOUS RECOMBINATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; REVERSE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; UPREGULATION;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84927511532     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00008     Document Type: Article

References (52)

1. Boratyn, G. M., Camacho, C., Cooper, P. S., Coulouris, G., Fong, A., and Ma, N. (2013). BLAST: a more efficient report with usability improvements. Nucleic Acids Res. 41, W29-W33. doi: 10.1093/nar/gkt282.
2. Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., and Schwede, T. (2009). Protein structure homology modeling using SWISS-MODEL workspace. Nat. Protoc. 4, 1-13. doi: 10.1038/nprot.2008.197.
3. Breidenstein, E. B., De La Fuente-Nunez, C., and Hancock, R. E. (2011). Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19, 419-426. doi: 10.1016/j.tim.2011.04.005.
4. Bruchmann, S., Dotsch, A., Nouri, B., Chaberny, I. F., and Haussler, S. (2013). Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance. Antimicrob. Agents Chemother. 57, 1361-1368. doi: 10.1128/aac.01581-12.
5. Cabot, G., Ocampo-Sosa, A. A., Tubau, F., Macia, M. D., Rodriguez, C., and Moya, B. (2011). Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother. 55, 1906-1911. doi: 10.1128/aac.01645-10.
6. Deziel, E., Gopalan, S., Tampakaki, A. P., Lepine, F., Padfield, K. E., and Saucier, M. (2005). The contribution of MvfR to Pseudomonas aeruginosa pathogenesis and quorum sensing circuitry regulation: multiple quorum sensing-regulated genes are modulated without affecting lasRI, rhlRI or the production of N-acyl-L-homoserine lactones. Mol. Microbiol. 55, 998-1014. doi: 10.1111/j.1365-2958.2004.04448.x.
7. Fargier, E., Mac Aogain, M., Mooij, M. J., Woods, D. F., Morrissey, J. P., and Dobson, A. D. (2012). MexT functions as a redox-responsive regulator modulating disulfide stress resistance in Pseudomonas aeruginosa. J. Bacteriol. 194, 3502-3511. doi: 10.1128/jb.06632-11.
8. Fetar, H., Gilmour, C., Klinoski, R., Daigle, D. M., Dean, C. R., and Poole, K. (2011). mexEF-oprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol. Antimicrob. Agents Chemother. 55, 508-514. doi: 10.1128/aac.00830-10.
9. Fournier, D., Richardot, C., Muller, E., Robert-Nicoud, M., Llanes, C., and Plesiat, P. (2013). Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 68, 1772-1780. doi: 10.1093/jac/dkt098.
10. Fuste, E., Lopez-Jimenez, L., Segura, C., Gainza, E., Vinuesa, T., and Vinas, M. (2013). Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa. J. Med. Microbiol. 62, 1317-1325. doi: 10.1099/jmm.0.058354-0.
11. Geiser, M., Cebe, R., Drewello, D., and Schmitz, R. (2001). Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. Biotechniques 31, 88-92.
12. Gellatly, S. L., and Hancock, R. E. (2013). Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog. Dis. 67, 159-173. doi: 10.1111/2049-632x.12033.
13. Hauser, A. R. (2009). The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7, 654-665. doi: 10.1038/nrmicro2199.
14. Hoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J., and Schweizer, H. P. (1998). A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212, 77-86.
15. Hocquet, D., Berthelot, P., Roussel-Delvallez, M., Favre, R., Jeannot, K., and Bajolet, O. (2007). Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob. Agents Chemother. 51, 3531-3536. doi: 10.1128/aac.00503-07.
16. Hocquet, D., Muller, A., Blanc, K., Plesiat, P., Talon, D., Monnet, D. L., et al. (2008). Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52, 1173-1175. doi: 10.1128/aac.01212-07.
17. Jimenez, P. N., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., and Quax, W. J. (2012). The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 76, 46-65. doi: 10.1128/mmbr.05007-11.
18. Jin, Y., Yang, H., Qiao, M., and Jin, S. (2011). MexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosa. J. Bacteriol. 193, 399-410. doi: 10.1128/jb.01079-10.
19. Juhas, M., Wiehlmann, L., Huber, B., Jordan, D., Lauber, J., and Salunkhe, P. (2004). Global regulation of quorum sensing and virulence by VqsR in Pseudomonas aeruginosa. Microbiology 150, 831-841. doi: 10.1099/mic.0.26906-0.
20. Khuntayaporn, P., Montakantikul, P., Santanirand, P., Kiratisin, P., and Chomnawang, M. T. (2013). Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand. Microbiol. Immunol. 57, 170-178. doi: 10.1111/1348-0421.12021.
21. Kiewitz, C., and Tummler, B. (2000). Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J. Bacteriol. 182, 3125-3135. doi: 10.1128/JB.182.11.3125-3135.2000.
22. Kohler, T., Epp, S. F., Curty, L. K., and Pechere, J. C. (1999). Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 181, 6300-6305.
23. Kohler, T., Van Delden, C., Curty, L. K., Hamzehpour, M. M., and Pechere, J. C. (2001). Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183, 5213-5222. doi: 10.1128/JB.183.18.5213-5222.2001.
24. Kumar, P., Henikoff, S., and Ng, P. C. (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081. doi: 10.1038/nprot.2009.86.
25. Lamarche, M. G., and Deziel, E. (2011). MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS ONE 6:e24310. doi: 10.1371/journal.pone.0024310.
26. Li, Y., Mima, T., Komori, Y., Morita, Y., Kuroda, T., and Mizushima, T. (2003). A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 52, 572-575. doi: 10.1093/jac/dkg390.
27. Linares, J. F., Lopez, J. A., Camafeita, E., Albar, J. P., Rojo, F., and Martinez, J. L. (2005). Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187, 1384-1391. doi: 10.1128/jb.187.4.1384-1391.2005.
28. Llanes, C., Kohler, T., Patry, I., Dehecq, B., Van Delden, C., and Plesiat, P. (2011). Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob. Agents Chemother. 55, 5676-5684. doi: 10.1128/aac.00101-11.
29. Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., and Warren, M. S. (1999). Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 1340-1346.
30. Maseda, H., Saito, K., Nakajima, A., and Nakae, T. (2000). Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 192, 107-112. doi: 10.1111/j.1574-6968.2000.tb09367.x.
31. Morita, Y., Gilmour, C., Metcalf, D., and Poole, K. (2009). Translational control of the antibiotic inducibility of the PA5471 gene required for mexXY multidrug efflux gene expression in Pseudomonas aeruginosa. J. Bacteriol. 191, 4966-4975. doi: 10.1128/jb.00073-09.
32. Morita, Y., Kimura, N., Mima, T., Mizushima, T., and Tsuchiya, T. (2001). Roles of MexXY-and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1. J. Gen. Appl. Microbiol. 47, 27-32. doi: 10.2323/jgam.47.27.
33. Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., and Mizushima, T. (1998). NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42, 1778-1782.
34. Morita, Y., Narita, S., Tomida, J., Tokuda, H., and Kawamura, Y. (2010). Application of an inducible system to engineer unmarked conditional mutants of essential genes of Pseudomonas aeruginosa. J. Microbiol. Methods 82, 205-213. doi: 10.1016/j.mimet.2010.06.001.
35. Morita, Y., Sobel, M. L., and Poole, K. (2006). Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J. Bacteriol. 188, 1847-1855. doi: 10.1128/jb.188.5.1847-1855.2006.
36. Morita, Y., Tomida, J., and Kawamura, Y. (2012a). MexXY multidrug efflux system of Pseudomonas aeruginosa. Front. Microbiol. 3:408. doi: 10.3389/fmicb.2012.00408.
37. Morita, Y., Tomida, J., and Kawamura, Y. (2012b). Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7. Microbiology 158, 1071-1083. doi: 10.1099/mic.0.054320-0.
38. Morita, Y., Tomida, J., and Kawamura, Y. (2014). Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol. 4:422. doi: 10.3389/fmicb.2013.00422.
39. Morita, Y., Tomida, J., and Kawamura, Y. (2015). "Resistance and response to anti-pseudomonas agents and biocides, "in Pseudomonas: New Aspects of Pseudomonas Biology, eds J. Ramos, J. B. Goldberg, and A. Filloux (New York, NY: Springer), 173-187.
40. Patel, J. B., Tenover, F. C., Turnidge, J. D., and Jorgensen, J. H. (2011). "Susceptibility test methods: dilution and disk diffusion methods, "in Manual of Clinical Microbiology, 10th Edn, eds J. Versalovic, K. C. Carroll, G. Funke, J. H. Jorgensen, M. L. Landry, and D. W. Warnock (Washington, DC: ASM Press), 1122-1143.
41. Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65. doi: 10.3389/fmicb.2011.00065.
42. Poole, K. (2013). "Pseudomonas aeruginosa efflux pumps, "in Microbial Efflux Pumps: Current Research, eds E. W. Yu, Q. Zhang, and M. H. Brown (Norfolk: Caiser Academic Press), 175-206.
43. Poole, K. (2014). Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more. Can. J. Microbiol. 60, 783-791. doi: 10.1139/cjm-2014-0666.
44. Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., and Yamasaki, T. (1996). Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21, 713-724.
45. Rossolini, G. M., Arena, F., Pecile, P., and Pollini, S. (2014). Update on the antibiotic resistance crisis. Curr. Opin. Pharmacol. 18c, 56-60. doi: 10.1016/j.coph.2014.09.006.
46. Roy, P. H., Tetu, S. G., Larouche, A., Elbourne, L., Tremblay, S., and Ren, Q. (2010). Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS ONE 5:e8842. doi: 10.1371/journal.pone.0008842.
47. Schweizer, H. P., Klassen, T. R., and Hoang, T. T. (1996). "Improved methods for gene analysis and expression in Pseudomonas, "in Molecular Biology of Pseudomonads, eds T. Nakazawa, D. Haas, and S. Silver (Washington, DC: ASM Press), 229-237.
48. Sobel, M. L., McKay, G. A., and Poole, K. (2003). Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 47, 3202-3207. doi: 10.1128/AAC.47.10.3202-3207.2003.
49. Sobel, M. L., Neshat, S., and Poole, K. (2005). Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J. Bacteriol. 187, 1246-1253. doi: 10.1128/jb.187.4.1246-1253.2005.
50. Trias, J., and Nikaido, H. (1990). Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J. Biol. Chem. 265, 15680-15684.
51. Vatcheva-Dobrevska, R., Mulet, X., Ivanov, I., Zamorano, L., Dobreva, E., and Velinov, T. (2013). Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals. Microb. Drug Resist. 19, 355-361. doi: 10.1089/mdr.2013.0004.
52. Winsor, G. L., Lam, D. K., Fleming, L., Lo, R., Whiteside, M. D., and Yu, N. Y. (2011). Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39, D596-D600. doi: 10.1093/nar/gkq869.